What this story covers

ResMed Inc.'s 2024 10-K highlights 11 percent revenue growth to 4 point 7 billion dollars, driven by 10 percent in sleep/respiratory devices and 17 percent in SaaS to 584 million dollars. Net income rose 14 percent to 1 point 0 billion dollars, with strong liquidity at 1 point 7 billion dollars. Segments show synergies, but risks include competition, supply chains, and regulations. Focus on innovation and out-of-hospital care positions for future growth.

Story snapshot